secwatch.observer — SEC 8-K summary
======================================

Issuer:     AXIM BIOTECHNOLOGIES, INC. (AXIM)
CIK:        0001514946
Form:       8-K
Filed at:   2022-02-16T23:59:59+00:00
Accession:  0001096906-22-000353
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AXIM raises $1.825M in new debt; retires $1.11M GS Capital note
---------------------------------------------------------------

- Issued two $250K short-term notes (1.5% interest, due March 10, 2022); one repaid on Feb 14.
- Issued seven convertible notes aggregate $1.325M at 3% interest, due 2032; conversion at 70% of avg two lowest closing prices.
- One $25K convertible note was acquired by director Blake N. Schroeder.
- Repaid GS Capital Partners note ($1.11M face) in full; accrued interest $21,876 paid via 173,390 restricted shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/0001096906-22-000353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/axim-20220210.htm
  HTML page:      https://secwatch.observer/filing/0001096906-22-000353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer